Migraine associated with gastrointestinal disorders: review of the literature and clinical implications

Saskia van Hemert, Anne C Breedveld, Jörgen M P Rovers, Jan P W Vermeiden, Ben J M Witteman, Marcel G Smits, Nicole M de Roos, Saskia van Hemert, Anne C Breedveld, Jörgen M P Rovers, Jan P W Vermeiden, Ben J M Witteman, Marcel G Smits, Nicole M de Roos

Abstract

Recent studies suggest that migraine may be associated with gastrointestinal (GI) disorders, including irritable bowel syndrome (IBS), inflammatory bowel syndrome, and celiac disease. Here, an overview of the associations between migraine and GI disorders is presented, as well as possible mechanistic links and clinical implications. People who regularly experience GI symptoms have a higher prevalence of headaches, with a stronger association with increasing headache frequency. Children with a mother with a history of migraine are more likely to have infantile colic. Children with migraine are more likely to have experienced infantile colic compared to controls. Several studies demonstrated significant associations between migraine and celiac disease, inflammatory bowel disease, and IBS. Possible underlying mechanisms of migraine and GI diseases could be increased gut permeability and inflammation. Therefore, it would be worthwhile to investigate these mechanisms further in migraine patients. These mechanisms also give a rationale to investigate the effects of the use of pre- and probiotics in migraine patients.

Keywords: celiac disease; colic; gastroparesis; inflammatory bowel disease; irritable bowel syndrome; leaky gut; migraine; probiotics.

Figures

Figure 1
Figure 1
The microbiota-gut-brain axis.

References

    1. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology (1999) 53:537–42.10.1212/WNL.53.3.537
    1. Bond DS, Roth J, Nash JM, Wing RR. Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obes Rev (2011) 12:e362–71.10.1111/j.1467-789X.2010.00791.x
    1. Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology (2005) 64:S9–1510.1212/WNL.64.10_suppl_2.S9
    1. Wang SJ, Chen PK, Fuh JL. Comorbidities of migraine. Front Neurol (2010) 1:16.
    1. Monteith T, Goadsby P. Acute migraine therapy: new drugs and new approaches. Curr Treat Options Neurol (2011) 13:1–14.10.1007/s11940-010-0105-6
    1. Samsam M, Covenas R, Ahangari R, Yajeya J. Neuropeptides and other chemical mediators, and the role of anti-inflammatory drugs in primary headaches. AntiInflamm AntiAllergy Agents Med Chem (2010) 9:170–8810.2174/1871523011009030170
    1. Sinclair SR, Kane SA, Van Der Schueren BJ, Xiao A, Willson KJ, Boyle J, et al. Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974). Br J Clin Pharmacol (2010) 69:15–22.10.1111/j.1365-2125.2009.03543.x
    1. Xanthos D, Gaderer S, Drdla R, Nuro E, Abramova A, Ellmeier W, et al. Central nervous system mast cells in peripheral inflammatory nociception. Mol Pain (2011) 7:42–58.10.1186/1744-8069-7-42
    1. Maneepak M, Le Grand S, Srikiatkhachorn A. Serotonin depletion increases nociception-evoked trigeminal NMDA receptor phosphorylation. Headache (2009) 49:375–82.10.1111/j.1526-4610.2009.01341.x
    1. Peterlin BL, Rapoport AM. Clinical pharmacology of the serotonin receptor agonist, zolmitriptan. Expert Opin Drug Metab Toxicol (2007) 3:899–911.10.1517/17425255.3.6.899
    1. Chai NC, Scher AI, Moghekar A, Bond DS, Peterlin BL. Obesity and headache: part I – a systematic review of the epidemiology of obesity and headache. Headache (2014) 54:219–34.10.1111/head.12296
    1. Russell M, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ (1995) 311:541–4.10.1136/bmj.311.7004.541
    1. Belkaid Y, Naik S. Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol (2013) 14:646–53.10.1038/ni.2604
    1. de Vos WM, de Vos EA. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev (2012) 70(Suppl 1):S45–56.10.1111/j.1753-4887.2012.00505.x
    1. Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun (2014) 38C:1–1210.1016/j.bbi.2013.12.015
    1. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol (2012) 10:735–42.10.1038/nrmicro2876
    1. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci (2012) 13:701–12.10.1038/nrn3346
    1. Chen X, D’Souza R, Hong ST. The role of gut microbiota in the gut-brain axis: current challenges and perspectives. Protein Cell (2013) 4:403–14.10.1007/s13238-013-3017-x
    1. Aamodt A, Stovner L, Hagen K, Zwart J-A. Comorbidity of headache and gastrointestinal complaints. The head-HUNT study. Cephalalgia (2008) 28:144–51.10.1111/j.1468-2982.2007.01486.x
    1. Christensen CJ, Johnson WD, Abell TL. Patients with cyclic vomiting pattern and diabetic gastropathy have more migraines, abnormal electrogastrograms, and gastric emptying. Scand J Gastroenterol (2008) 43:1076–81.10.1080/00365520802085411
    1. Parkman HP. Migraine and gastroparesis from a gastroenterologist’s perspective. Headache (2013) 53(Suppl 1):4–10.10.1111/head.12112
    1. Newman LC. Why triptan treatment can fail: focus on gastrointestinal manifestations of migraine. Headache (2013) 53(Suppl 1):11–6.10.1111/head.12111
    1. Yalcin H, Okuyucu EE, Ucar E, Duman T, Yilmazer S. Changes in liquid emptying in migraine patients: diagnosed with liquid phase gastric emptying scintigraphy. Intern Med J (2012) 42:455–9.10.1111/j.1445-5994.2012.02741.x
    1. Aurora SK, Papapetropoulos S, Kori SH, Kedar A, Abell TL. Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications. Cephalalgia (2013) 33:408–15.10.1177/0333102412473371
    1. Wessel MA, Cobb JC, Jackson EB, Harris GS, Jr, Detwiler AC. Paroxysmal fussing in infancy, sometimes called colic. Pediatrics (1954) 14:421–35.
    1. Lucassen PL, Assendelft WJ, Van Eijk JT, Gubbels JW, Douwes AC, Van Geldrop WJ. Systematic review of the occurrence of infantile colic in the community. Arch Dis Child (2001) 84:398–403.10.1136/adc.84.5.398
    1. Sung V, Collett S, De Gooyer T, Hiscock H, Tang M, Wake M. Probiotics to Prevent or Treat Excessive Infant Crying: Systematic Review and Meta-analysis. JAMA Pediatr. (2013) 167:1150–710.1001/jamapediatrics.2013.2572
    1. Sung V, Hiscock H, Tang ML, Mensah FK, Nation ML, Satzke C, et al. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ (2014) 348:g2107.10.1136/bmj.g2107
    1. Gelfand AA, Thomas KC, Goadsby PJ. Before the headache: infant colic as an early life expression of migraine. Neurology (2012) 79:1392–6.10.1212/WNL.0b013e31826c1b7b
    1. de Weerth C, Fuentes S, Puylaert P, De Vos WM. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics (2013) 131:e550–8.10.1542/peds.2012-1449
    1. Bruni O, Fabrizi P, Ottaviano S, Cortesi F, Giannotti F, Guidetti V. Prevalence of sleep disorders in childhood and adolescence with headache: a case-control study. Cephalalgia (1997) 17:492–8.10.1046/j.1468-2982.1997.1704492.x
    1. Jan MM, Al-Buhairi AR. Is infantile colic a migraine-related phenomenon? Clin Pediatr (Phila) (2001) 40:295–710.1177/000992280104000512
    1. Romanello S, Spiri D, Marcuzzi E, Zanin A, Boizeau P, Riviere S, et al. Association between childhood migraine and history of infantile colic. JAMA (2013) 309:1607–12.10.1001/jama.2013.747
    1. Talley NJ. Irritable bowel syndrome: definition, diagnosis and epidemiology. Baillieres Best Pract Res Clin Gastroenterol (1999) 13:371–84.10.1053/bega.1999.0033
    1. Muller-Lissner SA, Bollani S, Brummer RJ, Coremans G, Dapoigny M, Marshall JK, et al. Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion (2001) 64:200–4.10.1159/000048862
    1. Berg J, Stovner LJ. Cost of migraine and other headaches in Europe. Eur J Neurol (2005) 1:59–6210.1111/j.1468-1331.2005.01192.x
    1. Bixquert Jimenez M. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? Rev Esp Enferm Dig (2009) 101:553–64.10.4321/S1130-01082009000800006
    1. Zhou Q, Zhang B, Verne GN. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain (2009) 146:41–6.10.1016/j.pain.2009.06.017
    1. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol (2006) 6:26.10.1186/1471-230X-6-26
    1. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ (1992) 304:87–9010.1136/bmj.304.6819.87
    1. Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther (2004) 20:1195–203.10.1111/j.1365-2036.2004.02250.x
    1. Chang FY, Lu CL. Irritable bowel syndrome and migraine: bystanders or partners? J Neurogastroenterol Motil (2013) 19:301–11.10.5056/jnm.2013.19.3.301
    1. Park JW, Cho YS, Lee SY, Kim ES, Cho H, Shin HE, et al. Concomitant functional gastrointestinal symptoms influence psychological status in Korean migraine patients. Gut Liver (2013) 7:668–74.10.5009/gnl.2013.7.6.668
    1. Aydinlar EI, Dikmen PY, Tiftikci A, Saruc M, Aksu M, Gunsoy HG, et al. IgG-based elimination diet in migraine plus irritable bowel syndrome. Headache (2013) 53:514–25.10.1111/j.1526-4610.2012.02296.x
    1. Ulevitch RJ, Tobias PS. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol (1999) 11:19–22.10.1016/S0952-7915(99)80004-1
    1. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol (2005) 2:416–22.10.1038/ncpgasthep0259
    1. Holtmeier W, Caspary WF. Celiac disease. Orphanet J Rare Dis (2006) 1:3.10.1186/1750-1172-1-3
    1. Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology (2009) 137:1912–3310.1053/j.gastro.2009.09.008
    1. Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci (2009) 1165:195–205.10.1111/j.1749-6632.2009.04037.x
    1. Zelnik N, Pacht A, Obeid R, Lerner A. Range of neurologic disorders in patients with celiac disease. Pediatrics (2004) 113:1672–6.10.1542/peds.113.6.1672
    1. Dimitrova AK, Ungaro RC, Lebwohl B, Lewis SK, Tennyson CA, Green MW, et al. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache (2013) 53:344–55.10.1111/j.1526-4610.2012.02260.x
    1. Gabrielli M, Cremonini F, Fiore G, Addolorato G, Padalino C, Candelli M, et al. Association between migraine and celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol (2003) 98:625–9.10.1111/j.1572-0241.2003.07300.x
    1. Alehan F, Ozcay F, Erol I, Canan O, Cemil T. Increased risk for coeliac disease in paediatric patients with migraine. Cephalalgia (2008) 28:945–9.10.1111/j.1468-2982.2008.01630.x
    1. Borgna-Pignatti C, Fiumana E, Milani M, Calacoci M, Soriani S. Celiac disease in children with migraine. Pediatrics (2004) 114:1371.10.1542/peds.2004-1337
    1. Inaloo S, Dehghani SM, Farzadi F, Haghighat M, Imanieh MH. A comparative study of celiac disease in children with migraine headache and a normal control group. Turk J Gastroenterol (2011) 22:32–5.10.4318/tjg.2011.0153
    1. Rashtak S, Murray JA. Review article: coeliac disease, new approaches to therapy. Aliment Pharmacol Ther (2012) 35:768–81.10.1111/j.1365-2036.2012.05013.x
    1. Podolsky DK. Inflammatory bowel disease. N Engl J Med (2002) 347:417–2910.1056/NEJMra020831
    1. Sartor RB. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol (2006) 3:390–407.10.1038/ncpgasthep0528
    1. Ford S, Finkel AG, Isaacs KL. Migraine in patients with inflammatory bowel disorders. J Clin Gastroenterol (2009) 43:499.10.1097/MCG.0b013e318188be85
    1. Finkel AG, Yerry JA, Mann JD. Dietary considerations in migraine management: does a consistent diet improve migraine? Curr Pain Headache Rep (2013) 17:373.10.1007/s11916-013-0373-4
    1. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg (1998) 22:382–910.1007/s002689900401
    1. Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology (2007) 132:913–20.10.1053/j.gastro.2007.01.046
    1. Kemper RHA, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia (2001) 21:549–57.10.1046/j.1468-2982.2001.00196.x
    1. Téllez-Zenteno JF, Matijevic S, Wiebe S. Somatic comorbidity of epilepsy in the general population in Canada. Epilepsia (2005) 46:1955–62.10.1111/j.1528-1167.2005.00344.x
    1. Aamodt AH, Stovner LJ, Langhammer A, Hagen K, Zwart J-A. Is headache related to asthma, hay fever, and chronic bronchitis? The head-HUNT study. Headache (2007) 47:204–12.10.1111/j.1526-4610.2006.00597.x
    1. Kurth T, Schurks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ (2008) 337:a636–44.10.1136/bmj.a636
    1. Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, et al. Migraine and cardiovascular disease: a population-based study. Neurology (2010) 74:628–35.10.1212/WNL.0b013e3181d0cc8b
    1. Peterlin BL, Rapoport AM, Kurth T. Migraine and obesity: epidemiology, mechanisms, and implications. Headache (2010) 50:631–48.10.1111/j.1526-4610.2009.01554.x
    1. de Tommaso M, Federici A, Serpino C, Vecchio E, Franco G, Sardaro M, et al. Clinical features of headache patients with fibromyalgia comorbidity. J Headache Pain (2011) 12:629–3810.1007/s10194-011-0377-6
    1. Sachdev A, Marmura MJ. Metabolic syndrome and migraine. Front Neurol (2012) 3:161.10.3389/fneur.2012.00161
    1. Marchiando AM, Graham WV, Turner JR. Epithelial barriers in homeostasis and disease. Ann Rev Pathol (2010) 5:119–4410.1146/annurev.pathol.4.110807.092135
    1. Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol (2003) 18:479–97.10.1046/j.1440-1746.2003.03032.x
    1. van Nieuwenhoven MA, Geerling BJ, Deutz NE, Brouns F, Brummer RJ. The sensitivity of the lactulose/rhamnose gut permeability test. Eur J Clin Invest (1999) 29:160–5.10.1046/j.1365-2362.1999.00421.x
    1. Perrier C, Corthesy B. Gut permeability and food allergies. Clin Exp Allergy (2011) 41:20–810.1111/j.1365-2222.2010.03639.x
    1. Pascual J, Oterino A. IgG-mediated allergy: a new mechanism for migraine attacks? Cephalalgia (2010) 30:777–910.1177/0333102410364856
    1. Alpay K, Ertas M, Orhan EK, Ustay DK, Lieners C, Baykan B. Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial. Cephalalgia (2010) 30:829–37.10.1177/0333102410361404
    1. FAO/WHO. Evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO Expert Consultation. Cordoba, Argentina: (2001).
    1. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev (2010):CD003048.10.1002/14651858.CD003048.pub3
    1. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA (2012) 307:1959–69.10.1001/jama.2012.3507
    1. Goldenberg JZ, Ma SS, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev (2013) 5:CD006095.10.1002/14651858.CD006095.pub3
    1. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev (2011):CD005496.10.1002/14651858.CD005496.pub3
    1. Floch MH, Walker WA, Madsen K, Sanders ME, Macfarlane GT, Flint HJ, et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol (2011) 45(Suppl):S168–71.10.1097/MCG.0b013e318230928b
    1. Sanders ME, Guarner F, Guerrant R, Holt PR, Quigley EM, Sartor RB, et al. An update on the use and investigation of probiotics in health and disease. Gut (2013) 62:787–96.10.1136/gutjnl-2012-302504
    1. Ohland CL, Macnaughton WK. Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol (2010) 298:G807–19.10.1152/ajpgi.00243.2009
    1. Van Hemert S, Verwer J, Schuetz B. Clinical studies evaluating effects of probiotics on parameters of intestinal barrier function. Adv Microbiol (2013) 3:212–2110.4236/aim.2013.32032
    1. Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer R-JM, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol (2010) 298:G851–9.10.1152/ajpgi.00327.2009
    1. Sensenig J, Johnson M, Staverosky T. Treatment of migraine with targeted nutrition focused on improved assimilation and elimination. Altern Med Rev (2001) 6:488–94.
    1. White JF. Intestinal pathophysiology in autism. Exp Biol Med (2003) 228:639–49.
    1. Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased transloca tion of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett (2008) 29:117–24.
    1. Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis (2009) 24:27–5310.1007/s11011-008-9118-1

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir